CRISPR Therapeutics Ltd header image

CRISPR Therapeutics Ltd

CRSP

Equity

ISIN CH0334081137 / Valor 33408113

NASDAQ (2024-11-19)

USD 46.97-0.70%

CRISPR Therapeutics Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

CRISPR Therapeutics Ltd is a biotechnology company that focuses on developing gene-editing therapies. One of their key products is CASGEVY™, a CRISPR/Cas9 gene-edited therapy developed in collaboration with Vertex Pharmaceuticals Incorporated, which has received approval in some countries for treating patients with sickle cell disease or transfusion-dependent beta thalassemia. The company's innovative approach to gene editing has the potential to revolutionize the treatment of genetic diseases, offering hope to patients with previously untreatable conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-30.8%1Y

-43.0%3Y

-31.4%5Y

Performance

52.8%1Y

60.9%3Y

61.5%5Y

Volatility

4187 M

Market cap (USD)

432,225

Daily traded volume (Shares)

47.48 / 46.61

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Towa Yakuhin KK

Towa Yakuhin KK Valor: 248084

Annual Return

-50%0%+50%

Risk level

110

-1.26%JPY 2,818.00

Savaria Corp

Savaria Corp Valor: 1385257

Annual Return

-50%0%+50%

Risk level

110

1.26%CAD 22.55

STERIS PLC

STERIS PLC Valor: 47027903

Annual Return

-50%0%+50%

Risk level

110

-2.34%USD 212.00

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

-0.20%USD 117.13

Novartis Inc

Novartis Inc Valor: 567514

Annual Return

-50%0%+50%

Risk level

110

0.22%USD 103.27

GSK PLC

GSK PLC Valor: 120042705

Annual Return

-50%0%+50%

Risk level

110

-0.68%USD 33.46

Almirall SA

Almirall SA Valor: 3180354

Annual Return

-50%0%+50%

Risk level

110

-1.43%EUR 8.28

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

1.50%EUR 74.55

Faes Farma SA

Faes Farma SA Valor: 2837976

Annual Return

-50%0%+50%

Risk level

110

0.29%EUR 3.48

Meta Data Limited

Meta Data Limited Valor: 136954714

Annual Return

-50%0%+50%

Risk level

110

-77.97%EUR 0.56

SIX

FactSet

Clearbit

Logos provided by Clearbit